Abiopharma

🔍 Costello Keith Conan (Executive)

Company: Rimini Street, Inc. (RMNI)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: H
• Acquired 150,000 shares of Employee Stock Options (Right to Buy) at $4.96 per share (Derivative)
  Date: 2026-08-17 | Code: A | Expires: 2036-08-17 | equity_swap_involved: 0 | shares_owned_after: 150,000.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 150,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 150,000.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: The Stock Options are subject to time-based vesting conditions and will vest in three (3) equal annual installments on August 17, 2027, August 17, 2028 and August 17, 2029, generally subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2013 Equity Incentive Plan) through the applicable vesting date.
• F2: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting.
• F3: The Restricted Stock Units are subject to time-based vesting conditions and will vest in three (3) equal annual installments on August 17, 2027, August 17, 2028 and August 17, 2029, generally subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2013 Equity Incentive Plan) through the applicable vesting date.